🧪 Hypotheses

therapeutic 0.83

AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue responses

🧬 PRKAA1 🏥 neurodegeneration 📖 45🏛 2

✅ 0.85 ✨ 0.80 💥 0.75

## Mechanistic Overview...

therapeutic 0.81

Neutrophil Extracellular Trap (NET) Inhibition

🧬 PADI4 🏥 N/A 📖 10🏛 1

✅ 0.00 ✨ 0.41 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Targeted Butyrate Supplementation for Microglial Phenotype Modulation

🧬 GPR109A 🏥 neurodegeneration 📖 29🏛 3

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.80

Dual-Receptor Antibody Shuttling

🧬 N/A 🏥 alzheimers 📖 10🏛 1

✅ 0.55 ✨ 0.34 💥 0.00

## Mechanistic Overview...

therapeutic 0.80

Microglial TREM2-SYK Pathway Enhancement

🧬 TREM2 🏥 neurodegeneration 📖 8🏛 2

✅ 0.70 ✨ 0.60 💥 0.80

## Mechanistic Overview...

therapeutic 0.79

VCP-Mediated Autophagy Enhancement

🧬 VCP 🏥 neurodegeneration 📖 38🏛 1

✅ 0.64 ✨ 0.37 💥 0.00

## Mechanistic Overview...

therapeutic 0.78

Selective HDAC3 Inhibition with Cognitive Enhancement

🧬 HDAC3 🏥 neurodegeneration 📖 48🏛 3

✅ 0.70 ✨ 0.85 💥 0.80

## Mechanistic Overview...

therapeutic 0.77

Chromatin Accessibility Restoration via BRD4 Modulation

🧬 BRD4 🏥 neurodegeneration 📖 49🏛 3

✅ 0.60 ✨ 0.90 💥 0.70

## Mechanistic Overview...

therapeutic 0.74

GPX4 reserve failure gates selective ALS motor-neuron ferroptosis

🧬 GPX4 🏥 neurodegeneration 📖 8🏛 1

✅ 0.72 ✨ 0.61 💥 0.86

ALS-linked proteostasis stress lowers effective GPX4 reserve in vulnerable motor neurons, allowing oxidized phospholipids to cross a ferroptotic death...

therapeutic 0.74

Circadian-Synchronized Proteostasis Enhancement

🧬 CLOCK/ULK1 🏥 neurodegeneration 📖 28🏛 2

✅ 0.60 ✨ 0.80 💥 0.70

# Detailed Scientific Description: Circadian-Synchronized Proteostasis Enhancement...

therapeutic 0.74

PARP1 Inhibition Therapy

🧬 PARP1 🏥 neurodegeneration 📖 57🏛 2

✅ 1.00 ✨ 0.70 💥 0.60

## Mechanistic Overview...

therapeutic 0.73

SMPD1 (Acid Sphingomyelinase) Inhibition for Ceramide Reduction and BACE1 Regulation

🧬 SMPD1 🏥 neurodegeneration 📖 18🏛 1

✅ 0.82 ✨ 0.55 💥 0.75

**Molecular Mechanism and Rationale**...

therapeutic 0.72

Proteostasis Enhancement via APOE Chaperone Targeting

🧬 HSPA1A 🏥 neurodegeneration 📖 8🏛 3

✅ 0.85 ✨ 0.70 💥 0.75

## Mechanistic Overview...

therapeutic 0.72

Metabolic Reprogramming to Reverse Senescence

🧬 SIRT1,PGC1A,NAMPT 🏥 N/A 📖 11🏛 6

✅ 0.77 ✨ 0.70 💥 0.76

# Metabolic Reprogramming to Reverse Senescence in Neurodegeneration: A Mechanistic Hypothesis...

therapeutic 0.71

ACSL4 lipid remodeling creates ferroptosis-prone ALS membranes

🧬 ACSL4 🏥 neurodegeneration 📖 8🏛 1

✅ 0.67 ✨ 0.76 💥 0.78

Motor neurons with ALS proteostasis stress may upregulate ACSL4/LPCAT3-dependent PUFA-phospholipid remodeling, creating membranes that are unusually s...

therapeutic 0.71

Matrix Stiffness Normalization via Targeted Lysyl Oxidase Inhibition

🧬 LOX/LOXL1-4 🏥 neurodegeneration 📖 23🏛 2

✅ 0.75 ✨ 0.80 💥 0.70

## **Molecular Mechanism and Rationale**...

therapeutic 0.69

Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Therapy

🧬 ALOX15 🏥 neurodegeneration 📖 25🏛 2

✅ 0.40 ✨ 0.70 💥 0.70

## Mechanistic Overview...

therapeutic 0.68

STMN2 Restoration as a Prerequisite for Axon Growth After TDP-43 Clearance

🧬 STMN2 🏥 neurodegeneration 📖 12🏛 1

✅ 0.85 ✨ 0.70 💥 0.82

**Molecular Mechanism and Rationale**...

therapeutic 0.68

Temporal CAG Repeat Stabilization via CRISPR-Mediated DNA Mismatch Repair Modulation

🧬 MSH3, PMS1 🏥 neurodegeneration 📖 5🏛 3

✅ 0.40 ✨ 0.75 💥 0.70

## Mechanistic Overview...

therapeutic 0.68

R-Loop Resolution Enhancement Therapy

🧬 SETX 🏥 neurodegeneration 📖 32🏛 2

✅ 0.45 ✨ 0.80 💥 0.60

## Mechanistic Overview...

therapeutic 0.67

TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

🧬 TREM2/ACAT1/LXR 🏥 neuroimmunology 📖 8🏛 2

✅ 0.55 ✨ 0.65 💥 0.72

## Mechanistic Overview...

therapeutic 0.66

Labile iron pool expansion amplifies genotype-specific ALS ferroptosis

🧬 FTL 🏥 neurodegeneration 📖 0🏛 1

✅ 0.69 ✨ 0.55 💥 0.72

SOD1, TDP-43, and FUS pathology may converge on impaired iron buffering in motor neurons and glia, increasing labile iron that catalyzes lipid peroxid...

therapeutic 0.66

RNA Granule Nucleation Site Modulation

🧬 G3BP1 🏥 neurodegeneration 📖 36🏛 2

✅ 0.60 ✨ 0.65 💥 0.70

## Mechanistic Overview...

therapeutic 0.65

Arginine Methylation Enhancement Therapy

🧬 PRMT1 🏥 neurodegeneration 📖 34🏛 2

✅ 0.50 ✨ 0.90 💥 0.80

## Molecular Mechanism and Rationale...

therapeutic 0.65

Mitochondrial Calcium Buffering Enhancement via MCU Modulation

🧬 MCU 🏥 neurodegeneration 📖 31🏛 2

✅ 0.50 ✨ 0.60 💥 0.30

## Mechanistic Overview...

therapeutic 0.65

Apoptosis-Senescence Decision Point Intervention

🧬 TP53,BAX,BAK1,CASP3 🏥 N/A 📖 2🏛 1

✅ 0.20 ✨ 0.80 💥 0.00

## Mechanistic Overview...

therapeutic 0.65

CLU-APOE-TREM2 Tripartite Axis as a Coordinate Therapeutic Target

🧬 CLU-APOE-TREM2 axis (LXR/RXR pathway) 🏥 neurodegeneration 📖 12🏛 1

✅ 0.45 ✨ 0.55 💥 0.78

## Mechanistic Overview...

therapeutic 0.65

Epigenetic Reprogramming of Microglial Memory

🧬 DNMT3A, HDAC1/2 🏥 alzheimers 📖 7🏛 4

✅ 0.80 ✨ 0.80 💥 0.70

## Mechanistic Overview...

therapeutic 0.64

H1: TREM2 Agonism to Redirect APOE4-Enhanced Microglia from Synapse Pruning to Amyloid Clearance

🧬 TREM2 🏥 neurodegeneration 📖 11🏛 1

✅ 0.69 ✨ 0.57 💥 0.64

## Mechanistic Overview...

therapeutic 0.64

Glycine-Rich Domain Competitive Inhibition

🧬 TARDBP 🏥 neurodegeneration 📖 28🏛 2

✅ 0.45 ✨ 0.70 💥 0.60

## Mechanistic Overview...